Unknown

Dataset Information

0

Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals.

ABSTRACT: Monitoring of latent Mycobacterium tuberculosis infection may prevent disease. We tested an ESAT-6 and CFP-10-specific IFN-γ Elispot assay (RD1-Elispot) on 163 HIV-infected individuals living in a TB-endemic setting. An RD1-Elispot was performed every 3 months for a period of 3-21 months. 62% of RD1-Elispot negative individuals were positive by cultured Elispot. Fluctuations in T cell response were observed with rates of change ranging from -150 to +153 spot-forming cells (SFC)/200,000 PBMC in a 3-month period. To validate these responses we used an RD1-specific real time quantitative PCR assay for monokine-induced by IFN-γ (MIG) and IFN-γ inducible protein-10 (IP10) (MIG: r=0.6527, p=0.0114; IP-10: r=0.6967, p=0.0056; IP-10+MIG: r=0.7055, p=0.0048). During follow-up 30 individuals were placed on ARVs and 4 progressed to active TB. Fluctuations in SFC did not correlate with CD4 count, viral load, treatment initiation, or progression to active TB. The RD1-Elispot appears to have limited value in this setting.

SUBMITTER: Mitchell JE 

PROVIDER: S-EPMC3369919 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals.

Mitchell Jessica E JE   Chetty Shivan S   Govender Pamla P   Pillay Mona M   Jaggernath Manjeetha M   Kasmar Anne A   Ndung'u Thumbi T   Klenerman Paul P   Walker Bruce D BD   Kasprowicz Victoria O VO  

PloS one 20120607 6

Monitoring of latent Mycobacterium tuberculosis infection may prevent disease. We tested an ESAT-6 and CFP-10-specific IFN-γ Elispot assay (RD1-Elispot) on 163 HIV-infected individuals living in a TB-endemic setting. An RD1-Elispot was performed every 3 months for a period of 3-21 months. 62% of RD1-Elispot negative individuals were positive by cultured Elispot. Fluctuations in T cell response were observed with rates of change ranging from -150 to +153 spot-forming cells (SFC)/200,000 PBMC in a  ...[more]

Similar Datasets

Unknown Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients.
| S-EPMC5034964 | biostudies-literature
Unknown Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to <i>Mycobacterium tuberculosis</i>.
| S-EPMC8113814 | biostudies-literature
Unknown Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.
| S-EPMC2772522 | biostudies-literature
Unknown Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.
| S-EPMC4351361 | biostudies-literature
Unknown High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.
| S-EPMC4503667 | biostudies-literature
Unknown Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.
| S-EPMC3986199 | biostudies-other
Unknown Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
| S-EPMC2858810 | biostudies-literature
Unknown Dynamic post-translational modification profiling of Mycobacterium tuberculosis-infected primary macrophages.
| S-EPMC7030789 | biostudies-literature
Transcriptomics Transcriptional profiling of Mycobacterium tuberculosis H37Rv in whole blood from HIV- and HIV+ individuals
2014-03-31 | GSE49760 | GEO
Unknown Analysis of the Phenotype of <i>Mycobacterium tuberculosis</i>-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals.
| S-EPMC5554366 | biostudies-literature